Tackling big problems with small plasmids

Chrysaor Biologics is a Canadian biotechnology company developing next generation vaccines to fight against circulating pathogens.

Quick and effective vaccines against any protein sequence

We work backwards to design and manufacture plasmid DNA (pDNA) to encode our target of interest and stimulate an immune response against an identified pathogen.

A fresh take on vaccine design

A plasmid map outlining the vaccine sequence using BPE technology, where BPE backbone is <1,000 bp

Chrysaor Biologics has a ground-up approach to designing and developing novel vaccines against notable pathogens at incredibly low costs. Our team optimizes every step of vaccine design and manufacturing, from the expression cassette to the stability of our antigen, to the shelf life of the vaccine.

All of our DNA vaccines are built off the Best Plasmid Ever (BPE) vaccine vector, which contains only ~900 bp of bacterial sequences and no antibiotic resistance genes.

Vaccine development & timelines

Several in-house vaccine candidates are in development.

A chart outlining Chrysaor vaccine timeline targets for plasmid DNA vaccines targeting Influenza H5, SRS, and Rabies pathogens.